Charge Nurses Taking Charge, Challenging the Culture of Culture-Negative Sepsis, and Preventing Central-Line Infections to Reduce NICU Antibiotic Usage
Autor: | Josef Cortez, Samarth Shukla, Mark L. Hudak, Rima Dababneh, Cristina Hoopes, P. Sireesha Nandula, Bill Renfro, Colleen Timmons, Ana M Alvarez, Kartikeya Makker, Yvette McCarter, Marilyn Middlebrooks, Ma Ingyinn, Rita Hazboun, Jenny VanRavestein |
---|---|
Rok vydání: | 2020 |
Předmět: |
Catheterization
Central Venous medicine.medical_specialty Neonatal intensive care unit Charge nurses medicine.drug_class Antibiotics Sepsis Antimicrobial Stewardship 03 medical and health sciences 0302 clinical medicine Intensive Care Units Neonatal 030225 pediatrics medicine Humans 030212 general & internal medicine Central line business.industry Infant Newborn Obstetrics and Gynecology Hospital cost medicine.disease Anti-Bacterial Agents Nursing Supervisory Catheter-Related Infections Pediatrics Perinatology and Child Health Emergency medicine Antibiotic Stewardship Culture negative business |
Zdroj: | American Journal of Perinatology. 39:861-868 |
ISSN: | 1098-8785 0735-1631 |
Popis: | Objective We aimed to reduce our monthly antibiotic usage rate (AUR, days of treatment per 1,000 patient-days) in the neonatal intensive care unit (NICU) from a baseline of 330 (July 2015–April 2016) to 200 by December 2018. Study Design We identified three key drivers as follows: (1) engaging NICU charge nurses, (2) challenging the culture of culture-negative sepsis, and (3) reducing central-line associated bloodstream infections (CLABSI). Our main outcome was AUR. The percentage of culture-negative sepsis that was treated with antibiotics for >48 hours and CLABSI was our process measure. We used hospital cost/duration of hospitalization and mortality as our balancing measures. Results After testing several plan-do-study-act (PDSA) cycles, we saw a modest reduction in AUR from 330 in the year 2016 to 297 in the year 2017. However, we did not find a special-cause variation in AUR via statistical process control (SPC) analysis (u'-chart). Thereafter, we focused our efforts to reduce CLABSI in January 2018. As a result, our mean AUR fell to 217 by December 2018. Our continued efforts resulted in a sustained reduction in AUR beyond the goal period. Importantly, cost of hospitalization and mortality did not increase during the improvement period. Conclusion Our sequential quality improvement (QI) efforts led to a reduction in AUR. We implemented processes to establish a robust antibiotic stewardship program that included antibiotic time-outs led by NICU charge nurses and a focus on preventing CLABSI that were sustained beyond the QI period. Key Points |
Databáze: | OpenAIRE |
Externí odkaz: |